Viewing Study NCT01313858


Ignite Creation Date: 2025-12-25 @ 12:13 AM
Ignite Modification Date: 2026-01-12 @ 11:06 PM
Study NCT ID: NCT01313858
Status: COMPLETED
Last Update Posted: 2016-11-01
First Post: 2011-03-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Investigate the Use of Golimumab (SimponiĀ®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Arthritis, Rheumatoid View
None Arthritis, Psoriatic View
None Spondylitis, Ankylosing View
Keywords: